Cilostazol | 2393

Cilostazol is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC₅₀ = 0.2 µM) and anti-thrombotic agent. It inhibits platelet aggregation and is a direct arterial vasodilator.

Cilostazol is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC₅₀ = 0.2 µM) and anti-thrombotic agent.

2393 | Cilostazol DataSheet

Alternate Name/Synonyms: 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone

Appearance: White solid

Formulation: N/A

CAS Number: 73963-72-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₀H₂₇N₅O₂

Molecular Weight: 369.46

Cell-Permeable?: No

Purity: ≥98% by TLC

Solubilities: DMSO (~20 mg/ml)

Handling: Protect from light and air

Country of Origin: USA

Tag Line: A phosphodiesterase 3 (PDE3) inhibitor

MDL Number: MFCD00866780

PubChem CID: 2754

SMILES: C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4

InChi: InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)

InChi Key: RRGUKTPIGVIEKM-UHFFFAOYSA-N